Highly sensitive <i>MYD88</i> <sup>L265P</sup> mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemiaDaniela Drandi, Simone Ferrero, Elisa Genuardi et al.|Haematologica|2018Cited by 84
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practiceElisabeth Schorb, Andrés J.M. Ferreri, Tom Cummin et al.|British Journal of Haematology|2020Cited by 69
Interim 18-FDG-Positron Emission Tomography/Computed Tomography (PET) Failed to Predict Different Outcome in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab-CHOP.Patrizia Pregno, Umberto Vitolo, Annalisa Chiappella et al.|Blood|2009Cited by 12
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experienceChiara Ciochetto, Umberto Vitolo, Barbara Botto et al.|Annals of Hematology|2018Cited by 7